Literature DB >> 30971111

The importance of return to work: How to achieve optimal reintegration in ACS patients.

Rona Reibis1,2, Annett Salzwedel1, Ana Abreu3, Ugo Corra4, Constantinos Davos5, Wolfram Doehner6,7,8, Patrick Doherty9, Ines Frederix10,11,12, Dominique Hansen13, Marie Christine Iliou14, Carlo Vigorito15, Heinz Völler1,16.   

Abstract

The vocational reintegration of patients after an acute coronary syndrome is a crucial step towards complete convalescence from the social as well as the individual point of view. Return to work rates are determined by medical parameters such as left ventricular function, residual ischaemia and heart rhythm stability, as well as by occupational requirement profile such as blue or white collar work, night shifts and the ability to commute (which is, in part, determined by physical fitness). Psychosocial factors including depression, self-perceived health situation and pre-existing cognitive impairment determine the reintegration rate to a significant extent. Patients at risk of poor vocational outcomes should be identified in the early period of rehabilitation to avoid a reintegration failure and to prevent socio-professional exclusion with adverse psychological and financial consequences. A comprehensive healthcare pathway of acute coronary syndrome patients is initiated by cardiac rehabilitation, which includes specific algorithms and assessment tools for risk stratification and occupational restitution. As the first in its kind, this review addresses determinants and legal aspects of reintegration of patients experiencing an acute coronary syndrome, and offers practical advice on reintegration strategies particularly for vulnerable patients. It presents different approaches and scientific findings in the European countries and serves as a recommendation for action.

Entities:  

Keywords:  Return to work; acute coronary syndrome; pension insurance; predictors

Year:  2019        PMID: 30971111     DOI: 10.1177/2047487319839263

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  6 in total

1.  Perceived return-to-work pressure following cardiovascular disease is associated with age, sex, and diagnosis: a nationwide combined survey- and register-based cohort study.

Authors:  Sidsel Marie Bernt Jørgensen; Nina Føns Johnsen; Thomas Alexander Gerds; Stig Brøndum; Thomas Maribo; Gunnar Gislason; Maria Kristiansen
Journal:  BMC Public Health       Date:  2022-05-27       Impact factor: 4.135

2.  Patients' expectations of returning to work, co-morbid disorders and work capacity at discharge from cardiac rehabilitation.

Authors:  Annett Salzwedel; Rona Reibis; Miralem Hadzic; Hermann Buhlert; Heinz Völler
Journal:  Vasc Health Risk Manag       Date:  2019-08-14

3.  The Effectiveness of Case-management Rehabilitation Intervention in Facilitating Return to Work and Maintenance of Employment After Myocardial Infarction: Results of a Randomized Controlled Trial.

Authors:  Oren Zack; Samuel Melamed; Haim Silber; Tali Cinamon; Doron Levy; Shlomo Moshe
Journal:  Clin Rehabil       Date:  2022-02-22       Impact factor: 2.884

4.  Barriers That Obstruct Return to Work After Coronary Bypass Surgery: A Qualitative Study.

Authors:  Fredrike Blokzijl; Marisa Onrust; Willem Dieperink; Frederik Keus; Iwan C C van der Horst; Wolter Paans; Massimo A Mariani; Michiel F Reneman
Journal:  J Occup Rehabil       Date:  2021-06

5.  Validation of the Multidimensional Fatigue Inventory with Coronary Artery Disease Patients.

Authors:  Julija Gecaite-Stonciene; Adomas Bunevicius; Julius Burkauskas; Julija Brozaitiene; Julius Neverauskas; Narseta Mickuviene; Nijole Kazukauskiene
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

6.  A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome.

Authors:  Ernesto Dalli Peydró; Nuria Sanz Sevilla; María T Tuzón Segarra; Vicente Miró Palau; Jorge Sánchez Torrijos; Juan Cosín Sales
Journal:  Clin Cardiol       Date:  2021-12-24       Impact factor: 3.287

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.